GLENN LEVINE to Acute Disease
This is a "connection" page, showing publications GLENN LEVINE has written about Acute Disease.
Connection Strength
0.228
-
Utilization of catheterization and revascularization procedures in patients with non-ST segment elevation acute coronary syndrome over the last decade. Catheter Cardiovasc Interv. 2005 Oct; 66(2):149-57.
Score: 0.049
-
Degree of anticoagulation after one subcutaneous and one subsequent intravenous booster dose of enoxaparin: implications for patients with acute coronary syndromes undergoing early percutaneous coronary intervention. J Thromb Thrombolysis. 2004 Jun; 17(3):167-71.
Score: 0.045
-
Low-molecular-weight heparin during percutaneous coronary interventions: rationale, results, and recommendations. Catheter Cardiovasc Interv. 2003 Oct; 60(2):185-93.
Score: 0.043
-
Antithrombotic therapy in patients with acute coronary syndromes. Arch Intern Med. 2001 Apr 09; 161(7):937-48.
Score: 0.036
-
Impact of diabetes mellitus on percutaneous revascularization (CAVEAT-I). CAVEAT-I Investigators. Coronary Angioplasty Versus Excisional Atherectomy Trial. Am J Cardiol. 1997 Mar 15; 79(6):748-55.
Score: 0.027
-
Pharmacoinvasive management of acute coronary syndrome: incorporating the 2007 ACC/AHA guidelines: the CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report--III. J Invasive Cardiol. 2007 Dec; 19(12):525-38; quiz 539-40.
Score: 0.014
-
Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report. J Invasive Cardiol. 2006 Dec; 18(12):617-39.
Score: 0.013